MedPath

Ultrasound-Guided Fascia Iliaca Compartmental Block Versus Spinal Anesthesia in Femoral Thrombectomy

Phase 4
Completed
Conditions
Fascia Iliaca Compartmental Block
Femoral Thrombectomy
Spinal Anesthesia
Interventions
Drug: ultrasound guided fascia iliaca compartment block ( bupivacaine 0.25% )
Drug: Spinal Anesthesia (bupivacaine)
Registration Number
NCT06745986
Lead Sponsor
Port Said University hospital
Brief Summary

This study aims to assess the efficiency of Fascia Iliaca Compartmental Block in patients undergoing femoral thrombectomy versus spinal anesthesia.

Detailed Description

Anesthesia for lower limb revascularization consists of general anesthesia, neuraxial anesthesia and peripheral regional block. Fascia iliaca compartment block (FICB) is an anterior approach to the lumbar plexus and it blocks femoral nerve, LFCN, and limited numbers of nearby nerves such as ilioinguinal, genitor femoral.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • scheduled femoral thrombectomy,
  • both sexes,
  • aged between 40-65 years,
  • American Society of Anesthesiologists (ASA) II-III. Patients Criteria:
Exclusion Criteria
  • ASA status Grade IV, patient
  • refused to participate,
  • patients with contraindications to neuraxial anesthesia, such as systemic infection or history of allergy to anesthetic drugs
  • infection at the site of injection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Fascia iliaca groupultrasound guided fascia iliaca compartment block ( bupivacaine 0.25% )The ultrasound-guided fascia iliaca compartment block (FICB) group included 42 patients who had a fascia iliaca compartment block by bupivacaine 0.25% in a total volume of 40 ml.
spinal anesthesiaSpinal Anesthesia (bupivacaine)spinal anesthesia included 42 patients had spinal anesthesia with 2.5 ml bupivacaine 0.5%.
Primary Outcome Measures
NameTimeMethod
pain score postoperative24 hours

visual analogue score (VAS), with a scale from 0 to 10

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mansoura university hosbital

🇪🇬

New Damietta, Egypt

© Copyright 2025. All Rights Reserved by MedPath